Ocata Therapeutics Inc fka OCAT

[rocky301]

Some more to ponder,

Executive summary stated IRB done on DEC 6 but others at later times say different.

The Executive Summary you posted came out here on DEC 6,2010http://www.thechairmansblog.com/william-caldwell/2010-12-the-chairman’s-blog-post-a-big-“thank-you”-to-our-note-holders.html


DEC 6 Blog
In the coming weeks we will be finalizing our clinical sites for our Stargardt Phase I/II Clinical Trial, working with their respective Institutional Review Boards (IRBs) to gain approval for commencing patient selection and completing the final testing of our clinical grade cells to be used for the Trial.

DEC 9 article
So, I can’t speak for others, but for us; our patented differentiation processes are such that our cells are terminally and totally differentiated into the cell type that we’re dealing with. Once we do that, then we’ll move quickly into efficacy and that tells us, of course, “does it work?” And that’s why we’re starting out with multiple sites. Right now, I’m in the process of finalizing those sites and developing a relationship with the primary investigator- the surgeon at each of the sites. I’m working with the internal review boards to gain approval on the protocols on any specific issues that they may have relative to their particular situation and then we will initiate those trials when all of that is completed.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=57868481&txt2find=investigators